Skip to Main Content
PFF Help Center
(844) 825-5733
Facebook
LinkedIn
YouTube
Instagram
Join the PFF Registry
Donate
Shop PFF
Menu
Understanding PF
Newly Diagnosed: Start Here
PF Basics: Info for Newly Diagnosed Patients
About Pulmonary Fibrosis
What is Pulmonary Fibrosis?
Causes
Diagnosis
Symptoms
Glossary and Abbreviations
Types of Pulmonary Fibrosis
Idiopathic Pulmonary Fibrosis
Environmental
Occupational
Drug-Induced
Radiation-Induced
Autoimmune Connective Tissue Disease
Other Types of Pulmonary Fibrosis
Treatment Options
Supplemental Oxygen
Pulmonary Rehabilitation
Pulmonary Rehabilitation Toolkit
Symptom Management
Medication
Lung Transplantation
Patients & Caregivers
Medical and Support Resources
Find Medical Care
Find a Support Group
PFF Help Center
Pulmonary Rehabilitation Toolkit
For the Caregiver
Stories from the Heart
Clinical Trials
Medical Statements
Education Resources
Fact Sheets
Maintain Your Health
Videos
Webinars
Telemedicine
Educational Materials
Recursos de fibrosis pulmonar
PFF Insights Blog
Clinical Trials Blog
PFF Summit
Oxygen Therapy
What is Oxygen Therapy?
Benefits
Oxygen Rights and Resources
Oxygen Therapy FAQs
Join a Research Study
PFF Community Registry
APPLe Familial Pulmonary Fibrosis Study
PRECISIONS
Find a clinical trial
Researchers & Healthcare Providers
Clinical Resources
PFF Clinical Resource Hub
Webinars
CME/CE Library
Position Statements
Educational Materials
PFF Summit
Fact Sheets
Research Opportunities
PFF Community Registry
PFF Scholars and Other Research Opportunities
Familial Pulmonary Fibrosis Research Award
PROLIFIC
Community Engagement
Care Center Network
Nurse and Allied Health Network
Host an Event
Book a PFF Ambassador
Request Sponsorship Support
Ways to Give
Ways to Give
Workplace & Matching Giving
Planned Giving
Donor Advised Funds
Donate Stocks & Bonds
Qualified Charitable Distribution (QCD)
Donate Cryptocurrency
Donation FAQs
2026 Tax Law Changes
Albert Rose Legacy Society
Shop PFF
Honor and Memorial Giving
Make a Gift in Honor or Memory
Find a Tribute
Create a Tribute
Fundraising Events
PFF Walk
Broadway Belts for PFF!
Team PFF
Community Walk
Corporate Giving
Corporate Partners
PFF Corporate Committee
Donate Today
Mail-in Donations
Donate Monthly
Get Involved
Events
Attend an Event
Fundraise with Team PFF
Fundraising on Facebook
PFF Walk
PFF Summit 2025
Broadway Belts for PFF!
ILD Day
PFF Education Symposium
Let's Talk Cough
Volunteer
Join the PFF Community Registry
Start a Support Group
Be a PFF Advocate
Share Your Story
Become a PFF Ambassador
PF Awareness Month
Join a Board Committee
Shop PFF
PFF Walk
About the PFF Walk
Bay Area
Chicago
Dallas
National Walk Day
NYC Metro
Pittsburgh
Tampa
Washington, D.C.
Join the PFF Registry
What is the PFF Registry
Getting started
Submit a research proposal
History of the PFF Registry
Registry Report
Meet The Team
Sponsors
FAQ
About Us
Who We Are
Leadership
Mission & History
Medical Advisory Committees
Financials
Our 25 year anniversary
What We Do
The PFF is Me Strategic Plan
Patient Support Programs
Policy & Advocacy
PFF Funded Research
Education
News and Media
News
PFF In The Media
Breathe Bulletin
Media Resources
Careers
Contact Us
Search
Search
External News
Home
External News
NIH Awards Major Grant In Pulmonary Fibrosis Research
March 09, 2021
Moderna Announces Publication in The New England Journal of Medicine of Interim Results From Phase 1 Study of Its mRNA Vaccine Against COVID-19 (mRNA-1273)
March 09, 2021
Development of COVID-19 vaccine AZD1222 expands into US Phase III clinical trial across all adult age groups
March 09, 2021
Galecto, Inc. Receives U.S. and EU Orphan Drug Designations for GB0139 in Idiopathic Pulmonary Fibrosis
March 09, 2021
Baricitinib in Combination with Remdesivir Reduces Time to Recovery in Hospitalized Patients with COVID-19 in NIAID-Sponsored ACTT-2 Trial
March 09, 2021
Pfizer and BioNTech share positive early data on lead mRNA vaccine candidate BNT162B2 against COVID-19
March 09, 2021
FibroGen Announces First Patient Enrolled in Pamrevlumab Clinical Trial in Patients Hospitalized in U.S. with Acute COVID-19
March 09, 2021
Bellerophon Therapeutics Announces First Patient Treated in Phase 3 Clinical Study of INOpulse® Inhaled Nitric Oxide Therapy for COVID-19
March 09, 2021
Primary endpoint achieved with ziritaxestat in NOVESA trial in systemic sclerosis patients
March 09, 2021
Bellerophon Therapeutics Announces Publication of Cohort 1 of iNO-PF Phase 2/3 Study in the CHEST Journal and Participation in Webinar to Discuss Clinical Results
March 09, 2021
Bellerophon Therapeutics Announces First Patient Enrolled in Phase 3 REBUILD Study Evaluating INOpulse® for the Treatment of Fibrotic Interstitial Lung Disease
March 09, 2021
Galecto Publishes GB0139 Phase 2a Idiopathic Pulmonary Fibrosis (IPF) Results in European Respiratory Journal, Showing Marked Impact on Several IPF Biomarkers
March 09, 2021
United Therapeutics Receives FDA Orphan Drug Designation For Treprostinil For The Treatment Of Idiopathic Pulmonary Fibrosis
March 09, 2021
United Therapeutics Highlights Poster Presentations from the Recent CHEST 2020 Meeting
March 09, 2021
FDA Takes Key Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for First COVID-19 Vaccine
March 09, 2021
Capricor Therapeutics Announces U.S. FDA Acceptance of its IND Application for a Phase 2 Clinical Trial of CAP-1002 in Patients with COVID-19
March 09, 2021
Bellerophon Therapeutics Announces Results of Interim Analysis of Phase 3 COViNOX Study of INOpulse® for the Treatment of COVID-19
March 09, 2021
OncoImmune’s SACCOVID™ (CD24Fc) Exhibits Superb Therapeutic Efficacy—A Potential Breakthrough in Treating Severe and Critical COVID-19
March 09, 2021
AZD1222 vaccine met primary efficacy endpoint in preventing COVID-19
March 09, 2021
Pfizer and BioNTech Conclude Phase 3 Study of COVID-19 Vaccine Candidate, Meeting All Primary Efficacy Endpoints
March 09, 2021
1
2
3
4
5
6
7
8
9
